Health care stocks were declining premarket Friday, with The Health Care Select Sector SPDR Fund (XLV) 0.6% lower and the iShares Biotechnology ETF (IBB) down 1.1%.
Walgreens Boots Alliance (WBA) shares were up over 13% after the company reported fiscal Q1 results that topped analyst expectations, with a year-over-year increase in revenue.
Royalty Pharma (RPRX) shares were up more than 4% after the company said it has agreed to acquire its external manager, RP Management for about $1.10 billion, including 24.5 million in shares that will vest over five to nine years, about $100 million in cash, and the assumption of $380 million of debt.
Neogen (NEOG) shares were down more than 9% after the company lowered its fiscal 2025 revenue guidance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.